Cigna Group (CI) executive compensation, 2026 proxy

David M. Cordani, Chair and Chief Executive Officer, was paid $22.9M in 2025, down 2% from $23.3M the year before. The CEO-to-median-employee pay ratio was 310:1, on median employee pay of $73,674.

Filed
March 13, 2026
Annual meeting
April 22, 2026
Pay year
2025
Named executives
7
CEO total pay
$22.9M-2% vs prior year
CEO to median employee
310:1median $73,674
CEO pay in equity
76%$17.3M in awards
Prior say-on-pay support
89%of votes cast
CEO Performance-Based Compensation
92%Percentage of total CEO compensation for 2025
Full-Year Revenue Growth
11%Growth to $275 billion in total revenue
Shareholder Return of Capital
$5.2BReturned through share repurchases and dividends

How Cordani was paid

$22.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary7%Stock awards61%Option awards15%Non-equity incentive14%Pension and deferred comp0%All other compensation3%

Named executive officers

ExecutiveTotal
David M. CordaniChair and Chief Executive Officer$22,866,134
Ann M. DennisonExecutive Vice President, Chief Financial Officer, The Cigna Group$4,691,526
Brian C. EvankoPresident and Chief Operating Officer$9,998,401
Nicole S. JonesExecutive Vice President, Chief Administrative Officer, and General Counsel$5,955,936
Everett NevilleExecutive Vice President, Strategy and Business Development$4,073,915
Eric P. PalmerFormer Executive Vice President, Enterprise Strategy, The Cigna Group$12,274,760
Noelle K. EderFormer Executive Vice President, Global Chief Information Officer$4,312,795

What changed and why

  • $22.9MDavid M. Cordani received total compensation of $22,866,134 in fiscal year 2025, representing a slight decrease from the prior year.
  • $275BFull-year total revenue grew by 11% to reach $275 billion in 2025.
  • $6BShareholders net income for the year was achieved at $6 billion, alongside adjusted income from operations of $8 billion.
  • The company aligned executive compensation with customer and patient satisfaction using Net Promoter Score metrics.
  • Brian C. Evanko was appointed as CEO effective July 1, 2026, succeeding David M. Cordani, who will become Executive Chair.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.